NS-304 Size:Solid 2 mg OC(=O)CC1=CC(=CC=C1)OCCCN(CC(C1C=CC=CC=1)C1C=CC=CC=1)CC1=CC=CC(=C1Cl)C(F)(F)F

OC(=O)CC1=CC(=CC=C1)OCCCN(CC(C1C=CC=CC=1)C1C=CC=CC=1)CC1=CC=CC(=C1Cl)C(F)(F)F

1239908-20-3

PubMed PMID: 15298067

Formula: C15H15NO

NS-304 Size:Solid 2 mg OC(=O)CC1=CC(=CC=C1)OCCCN(CC(C1C=CC=CC=1)C1C=CC=CC=1)CC1=CC=CC(=C1Cl)C(F)(F)FSelexipag, also known as ACT 293987 and NS 304, is a a first in class orally available selective non prostanoid IP receptor agonist, which is currently in development by Actelion as a treatment of pulmonary arterial hypertension. Selexipag and its active metabolite, ACT 333679, are agonists at the prostacyclin receptor, which leads to vasodilation in the pulmonary circulation. Product information CAS Number: 475086 01 2 Molecular Weight: 496. 62